Vertex Pharmaceuticals(DE:VX1)
€494.10+6.90 (+1.42%)
DE:VX1
Vertex Pharmaceuticals earnings date
€494.10
At close:+6.90 (+1.42%)
Vertex Pharmaceuticals (VX1) Q1 2023 Earnings Report
23 Followers
DE:VX1 Q1 2023 EPS Results
- Actual EPS
- EUR 2.76
- Consensus EPS
- EUR 2.72
- Beat/Miss
- Beat by +EUR 0.03
- One Year Ago EPS
- EUR 3.18
DE:VX1 Q1 2023 Revenue Results
- Actual Revenue
- EUR 2.13B
- Expected Revenue
- EUR 2.11B
- Beat/Miss
- Beat by +EUR 15.06M
- YoY Revenue Growth
- +13.26%
Earnings Announcement Details
- Quarter
- Q1 2023
- Date
- 05/01/2023
- Time
- After Close
- Conference Call
- Monday, May 1, 2023
DE:VX1 Upcoming Earnings
Vertex Pharmaceuticals's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q1 2023 Earnings Call Audio
DE:VX1 Q1 2023 Earnings Call
0:00 / 0:00
Q1 2023 Earnings Slide Deck
Q1 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:VX1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q4) | 3.79- | 4.55 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 4.354.30 | 4.34 | -0.83% (-0.04) | |
| Aug 03, 2026 | 2026 (Q2) | 4.294.28 | 4.09 | 4.65% (+0.19) | |
| May 04, 2026 | 2026 (Q1) | 3.844.04 | 3.67 | 10.10% (+0.37) | |
| Feb 12, 2026 | 2025 (Q4) | 4.624.55 | 3.6 | 26.38% (+0.95) | |
| Nov 03, 2025 | 2025 (Q3) | 4.134.34 | 3.96 | 9.59% (+0.38) | |
| Aug 06, 2025 | 2025 (Q2) | 3.884.09 | -11.6 | 135.23% (+15.68) | |
| May 05, 2025 | 2025 (Q1) | 3.903.67 | 4.3 | -14.71% (-0.63) | |
| Feb 10, 2025 | 2024 (Q4) | 3.633.60 | 3.8 | -5.24% (-0.20) | |
| Nov 04, 2024 | 2024 (Q3) | 3.693.96 | 3.69 | 7.35% (+0.27) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
